Debiopharm International Sa

This is a first-in-human study to find a safe dose and see if a new oral drug, Debio 0123, can help control advanced solid tumors. It will enroll about 66 adults whose cancer has grown despite standard treatments. The study has two parts: first to find the right dose, and then to…

This study is testing a new, long-acting injection called Debio 4326 for children with central precocious puberty, a condition where puberty starts too early. The goal is to see if a single yearly injection can safely pause the early puberty process for a full year, allowing chil…

This early-stage study is testing a new oral drug called Debio 0123 in combination with two standard chemotherapy drugs (carboplatin and etoposide). It aims to find a safe dose and see if the combination can help control tumors in adults whose small cell lung cancer has returned …